Duke Health

Skip to main content

Search

Associate Vice President, DUHS Clinical Labs and Vice Chair of Clinical Pathology, Department of Pathology
Mike Datto, MD, PhD

Mike Datto, MD, PhD is an AP/CP/MGP board-certified pathologist, vice chair of clinical pathology for the department of pathology at Duke University and the medical director and associate vice president for Duke University Health System Clinical Laboratories. In his role as associate vice president, Datto is responsible for maintaining the standards of the College of American Pathologists and CLIA/CMS within all clinical laboratories at Duke. 

Specifically, Datto oversees clinical testing; develops quality management systems and proficiency testing programs; provides consultation with ordering physicians; develops strategic plans in line with patient, physician and health system leadership needs; coordinates research and development; ensures adequate and appropriately trained personnel; and provides profession interpretation for molecular diagnostic testing including the wide range of PCR, quantitative PCR, sequencing, NGS and FISH based tests for inherited genetic diseases, hematologic malignancies, solid tumors and infectious diseases.

In the past, Datto worked in the Lab of Xiao-Fan Wang, defining the mechanisms by which transforming growth factor beta exerts its cellular actions in health and disease. Following the completion of medical school, Datto trained as a resident in pathology at Duke. He has been on faculty in the department of pathology ever since.

Outside of Duke, Datto has served on many national committees as a leader in laboratory medicine, including service to the College of American Pathologists as the Chair of the Accreditation Committee, and overseeing the accreditation decisions for all CAP accredited laboratories.

Datto received a BA from Johns Hopkins University in Biology. He went on to receive his MD and PhD from Duke University as part of the Medical Scientists Training Program.

Social Media
Cameron Knowles
Senior Vice President and Chief Medical Officer, DUHS and Chief Quality Officer, Duke Health
Richard P. Shannon, MD

Richard P. Shannon, MD serves as the Senior Vice President and Chief Medical Officer for Duke University Health System. In this role, Shannon works in partnership with our Nurse, Physician and Administrator triads to oversee governance, strategy and operational outcomes for our comprehensive centers of excellence, including Neurosciences, Heart, Oncology and Musculoskeletal.

As Chief Quality Officer for Duke Health, Shannon is responsible for the overall direction, leadership and operational management of the quality and safety programs of Duke Health, and provides leadership in strengthening a quality culture where everyone is engaged and respected.

Shannon received his BA from Princeton University and his MD from the University of Connecticut School of Medicine. He completed his training in internal medicine at Beth Israel Hospital, his cardiovascular training at Massachusetts General Hospital, and was the Francis Weld Peabody Fellow and Associate Professor of Medicine at Harvard Medical School before becoming the Claude R. Joyner Professor of Medicine at Drexel University College of Medicine.

Prior to joining Duke Health, he served as executive vice president for health affairs at the University of Virginia, where he worked with faculty and staff to transform the UVA Health System into the premier health care provider in Virginia. Shannon has also served as the Frank Wister Thomas Professor and Chair of the Department of Medicine at the University of Pennsylvania Perelman School of Medicine, and as Chair of the Department of Medicine at Allegheny General Hospital in Pittsburgh. Shannon has received numerous teaching awards from Harvard Medical School, Drexel University College of Medicine and the University of Pennsylvania School of Medicine.

Shannon’s investigative interests are in the areas of myocardial metabolism and heart failure, specifically the role of energetics in the progression of heart failure. Shannon’s lab was the first to discover the beneficial CV actions of incretins which formed the basis for Ventrigen, LLC, a company designed to develop incretins for the use in treating heart failure.

Shannon's pioneering work in patient safety is chronicled in the chapter “First, Do No Harm” in Charles Kenney’s The Best Practice - How the New Quality Movement is Transforming Medicine. His innovative work also has been featured in The Wall Street Journal and The New York Times, on CNN and CNBC news segments, and on ABC's "20/20", and was a centerpiece for the PBS report entitled "Remaking American Medicine." 

Shannon is an elected member of honorary organizations, including the American Society for Clinical Investigation, and served as a senior fellow of the Leonard Davis Institute of Health Economics at the University of Pennsylvania. He currently is a teaching fellow for the Institute of Healthcare Improvement. He is a Director of the National Institutes of Health, Clinical Center Research Hospital Board; and a member of the Boards of Directors of the Kaiser Foundation Hospitals and Kaiser Foundation Health Plan, Inc., where he chairs the Quality Health Improvement Committee.

Dean, Duke University School of Nursing; Vice Chancellor for Nursing Affairs, Duke University; Associate Vice President for Academic Affairs for Nursing, DUHS
Marion Broome, PhD, RN, FAAN

Marion E. Broome, PhD, RN, FAAN, is dean and Ruby Wilson Professor of Nursing at the Duke University School of Nursing, Vice Chancellor for Nursing Affairs at Duke University, and Associate Vice President for Academic Affairs for Nursing at Duke University Health System. Prior to joining Duke, Broome was dean of the Indiana University School of Nursing, where she was awarded the rank of Distinguished Professor.

Widely regarded as an expert, scholar and leader in pediatric nursing research and practice, Broome has been funded externally by the American Cancer Society and the National Institutes of Health (NIH), as well as private foundations for more than 15 years to conduct research in which she developed and tested interventions designed to assist children to cope with acute and chronic pain. In 2000, Broome extended her research into the area of research ethics related to informed consent and assent for children in research, research misconduct in clinical trials and, most recently, ethical dilemmas in publishing. Her research is published in more than 100 papers in 50 refereed nursing, medicine and interdisciplinary journals. She also has published five books and 15 chapters in books and consumer publications.

Broome served a four-year term as an appointed member of the Nursing Science Study Section at the NIH, from 2008 to 2012. Prior to that time she served as a permanent member of Study Section in the Center for Scientific Review at NIH. Broome also has served as president of the Society for Pediatric Nurses and has been on the boards of the Association for the Care of Children's Health and the Midwest Nursing Research Society. Currently, Broome is editor-in-chief of Nursing Outlook, the official journal of the American Academy of Nursing (AAN) and the Council for the Advancement of Nursing Science. Broome has been a Fellow of the American Academy of Nursing since 1994. She was inducted into the Sigma Theta Tau International Researcher Hall of Fame in 2010. Selected honors include Outstanding Alumnus for Georgia Health Sciences University and the University of South Carolina. In 2012, she was selected to receive the National League of Nursing Award for Outstanding Leadership in Nursing Education. In 2014, she was awarded the President’s Medal for Excellence at Indiana University.

Broome currently consults with a variety of schools of nursing and Magnet-designated hospitals related to evidence-based practice programs, research implementation and professional development programs for nurses and faculty. In June 2014, the Friends of the National Institute of Nursing Research (FNINR) named Broome as one of 12 nursing leaders nationwide for the inaugural FNINR Ambassadors for Scientific Advancement Program.

Broome earned her BSN degree from the Medical College of Georgia, her MSN from the University of South Carolina and her PhD from the University of Georgia.